跳至主要内容
临床试验/CTRI/2009/091/000514
CTRI/2009/091/000514已完成3 期

A prospective, open labeled, randomised, comparative efficacy & safety trial of polyherbal formulation WH- 1 with Fluconazole, Tinidazole & FAS-3 kit in female patients with vaginitis.

Dr. V.R. Bapat,Ayurvedic Consultant# 375 First B main.First Phase, Girinagar,Bangalore 560085Tel: 080 ? 26720139E mail : vrbapat@yahoo.co.in0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • After getting the IERB approval.
  • Married women in the age of 18 to 60 years.
  • Patients/Subjects diagnosed to have vaginitis.
  • Subjects proven to be eligible through clinical, biochemical examination.
  • ?No clinical evidence of hepatic or renal impairment.
  • ?Subjects who have given written informed consent.
  • ?Female patients / subjects who have given consent for their partner to be included in trial

排除标准

  • Pregnant & lactating women.
  • Chronic disorder such as cardiac (hypertension uncontrolled, arrhythmia), diabetes and endocrine dysfunction (thyroid uncontrolled) as assessed through clinical examination / lab investigations.
  • Women with multiple partners.?
  • Subjects with h/o smoking, alcohol & drug dependence etc.
  • History of Allergy to herbal medication.
  • Participating in any other study within six weeks preceding day one of the study.
  • ?Patients currently on medication such as Metronidazole & other antifungal drugs.

研究者

发起方
Dr. V.R. Bapat,Ayurvedic Consultant# 375 First B main.First Phase, Girinagar,Bangalore 560085Tel: 080 ? 26720139E mail : vrbapat@yahoo.co.in

相似试验